Vyant Bio, Inc.
SEC CIK 1349929 · VYNT · last insider filing 2023-02-27
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Hansen Paul R. | Director | filed 2021 - 2023 |
| Fletcher R John | Director | filed 2021 - 2023 |
| Horobin Joanna | Director | filed 2021 - 2023 |
| Harris Geoffrey E. | Director | filed 2014 - 2023 |
| Boehm Marcus | Director | filed 2021 - 2022 |
| Mcleod Howard | Director | filed 2014 - 2022 |
| Yeh Yung-Ping | Director · Chief Innovation Officer | filed 2021 - 2022 |
| Roberts John A | Director · Chief Operating Officer | filed 2016 - 2022 |
| Prendergast Franklyn G | Director | filed 2013 - 2019 |
| Chaganti Raju S.K. | Director | filed 2013 - 2019 |
| Cannon Edmund | Director | filed 2013 - 2019 |
| Pappajohn John | Director | filed 2013 - 2019 |
| Widmann Thomas F | Director | filed 2017 - 2017 |
| Welsh Michael J. | Director | filed 2014 - 2017 |
| Sharma Panna | Director · President & CEO | filed 2013 - 2017 |
| Brownlie Keith L | Director | filed 2013 - 2014 |
| Rothman Paul | Director | filed 2014 - 2014 |
| Pecora Andrew L | Director | filed 2013 - 2013 |
| Thompson Tommy G | Director | filed 2013 - 2013 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Lafrence Andrew D.C. | Chief Financial Officer | filed 2021 - 2022 |
| Fremeau Robert Thomas Jr. | Chief Scientific Officer | filed 2021 - 2022 |
| Brandt Ralf | President, Discovery Services | filed 2017 - 2021 |
| Miles Michael Glenn | Chief Financial Officer | filed 2018 - 2020 |
| Finger William Lansing | EVP Precision Medicine | filed 2019 - 2019 |
| Mccartney Michael Brian | Chief Commercial Officer | filed 2018 - 2018 |
| Shaknovich Rita | VP of Hematopathology Services | filed 2015 - 2018 |
| Gitelman Igor | Chief Accounting Officer | filed 2017 - 2017 |
| Sitar Edward J | Chief Financial Officer | filed 2014 - 2016 |
| Hepburn Steven | VP of Biopharma Marketing | filed 2015 - 2015 |
| El Naggar Jane Houldsworth | VP of Research and Development | filed 2013 - 2014 |
| Czerepak Elizabeth | Chief Financial Officer | filed 2013 - 2013 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.